216 related articles for article (PubMed ID: 28785772)
1. Low-dose total skin electron beam therapy for cutaneous lymphoma : Minimal risk of acute toxicities.
Kroeger K; Elsayad K; Moustakis C; Haverkamp U; Eich HT
Strahlenther Onkol; 2017 Dec; 193(12):1024-1030. PubMed ID: 28785772
[TBL] [Abstract][Full Text] [Related]
2. Total Skin Electron Beam Therapy as Part of Multimodal Treatment Strategies for Primary Cutaneous T-Cell Lymphoma.
Elsayad K; Susek KH; Eich HT
Oncol Res Treat; 2017; 40(5):244-252. PubMed ID: 28448985
[TBL] [Abstract][Full Text] [Related]
3. Palliative total skin electron beam therapy (TSEBT) for advanced cutaneous T-cell lymphoma.
Funk A; Hensley F; Krempien R; Neuhof D; Van Kampen M; Treiber M; Roeder F; Timke C; Herfarth K; Helmbold P; Debus J; Bischof M
Eur J Dermatol; 2008; 18(3):308-12. PubMed ID: 18474461
[TBL] [Abstract][Full Text] [Related]
4. Total skin electron beam therapy for cutaneous T-cell lymphoma: a nationwide cohort study from Denmark.
Lindahl LM; Kamstrup MR; Petersen PM; Wirén J; Fenger-Grøn M; Gniadecki R; Iversen L; Specht L
Acta Oncol; 2011 Nov; 50(8):1199-205. PubMed ID: 21736502
[TBL] [Abstract][Full Text] [Related]
5. Low-dose (10-Gy) total skin electron beam therapy for cutaneous T-cell lymphoma: an open clinical study and pooled data analysis.
Kamstrup MR; Gniadecki R; Iversen L; Skov L; Petersen PM; Loft A; Specht L
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):138-43. PubMed ID: 25863761
[TBL] [Abstract][Full Text] [Related]
6. Total Skin Electron Beam for Primary Cutaneous T-cell Lymphoma.
Elsayad K; Kriz J; Moustakis C; Scobioala S; Reinartz G; Haverkamp U; Willich N; Weishaupt C; Stadler R; Sunderkötter C; Eich HT
Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1077-86. PubMed ID: 26581145
[TBL] [Abstract][Full Text] [Related]
7. Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: results of a pooled analysis from 3 phase-II clinical trials.
Hoppe RT; Harrison C; Tavallaee M; Bashey S; Sundram U; Li S; Million L; Dabaja B; Gangar P; Duvic M; Kim YH
J Am Acad Dermatol; 2015 Feb; 72(2):286-92. PubMed ID: 25476993
[TBL] [Abstract][Full Text] [Related]
8. Extent of skin involvement as a prognostic indicator of disease free and overall survival of patients with T3 cutaneous T-cell lymphoma treated with total skin electron beam radiation therapy.
Quiros PA; Kacinski BM; Wilson LD
Cancer; 1996 May; 77(9):1912-7. PubMed ID: 8646693
[TBL] [Abstract][Full Text] [Related]
9. Acute and sub-acute toxicity profile of ultra-hypofractionated low-dose total skin electron beam with two 4 Gy fractions for cutaneous T cell lymphoma.
Rolf D; Elsayad K; Eich HT
J Cancer Res Clin Oncol; 2021 Jun; 147(6):1757-1761. PubMed ID: 33219856
[TBL] [Abstract][Full Text] [Related]
10. Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides).
Quirós PA; Jones GW; Kacinski BM; Braverman IM; Heald PW; Edelson RL; Wilson LD
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):1027-35. PubMed ID: 9276369
[TBL] [Abstract][Full Text] [Related]
11. Total Skin Electron Beam Therapy in the Treatment of Mycosis Fungoides: A Review of Conventional and Low-Dose Regimens.
Chowdhary M; Chhabra AM; Kharod S; Marwaha G
Clin Lymphoma Myeloma Leuk; 2016 Dec; 16(12):662-671. PubMed ID: 27692530
[TBL] [Abstract][Full Text] [Related]
12. Ultimate results of radiation therapy for T1-T2 mycosis fungoides (including reirradiation).
Ysebaert L; Truc G; Dalac S; Lambert D; Petrella T; Barillot I; Naudy S; Horiot JC; Maingon P
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1128-34. PubMed ID: 15001254
[TBL] [Abstract][Full Text] [Related]
13. Patient perspectives regarding the value of total skin electron beam therapy for cutaneous T-cell lymphoma/mycosis fungoides: a pilot study.
Yu JB; Khan AM; Jones GW; Reavely MM; Wilson LD
Am J Clin Oncol; 2009 Apr; 32(2):142-4. PubMed ID: 19307950
[TBL] [Abstract][Full Text] [Related]
14. Total skin electron beam therapy as palliative treatment for cutaneous manifestations of advanced, therapy-refractory cutaneous lymphoma and leukemia.
Hauswald H; Zwicker F; Rochet N; Uhl M; Hensley F; Debus J; Herfarth K; Bischof M
Radiat Oncol; 2012 Jul; 7():118. PubMed ID: 22838493
[TBL] [Abstract][Full Text] [Related]
15. Acute toxicity and risk of infection during total skin electron beam therapy for mycosis fungoides.
Lloyd S; Chen Z; Foss FM; Girardi M; Wilson LD
J Am Acad Dermatol; 2013 Oct; 69(4):537-43. PubMed ID: 23849563
[TBL] [Abstract][Full Text] [Related]
16. Additional courses of total skin electron beam therapy in the treatment of patients with recurrent cutaneous T-cell lymphoma.
Wilson LD; Quiros PA; Kolenik SA; Heald PW; Braverman IM; Edelson RL; Kacinski BM
J Am Acad Dermatol; 1996 Jul; 35(1):69-73. PubMed ID: 8682967
[TBL] [Abstract][Full Text] [Related]
17. Systemic chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapy.
Wilson LD; Licata AL; Braverman IM; Edelson RL; Heald PW; Feldman AM; Kacinski BM
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):987-95. PubMed ID: 7607973
[TBL] [Abstract][Full Text] [Related]
18. Low-dose total skin electron beam therapy: Quality of life improvement and clinical impact of maintenance and adjuvant treatment in patients with mycosis fungoides or Sezary syndrome.
Elsayad K; Kroeger K; Greve B; Moustakis C; Assaf C; Stadler R; Lenz G; Weishaupt C; Eich HT
Strahlenther Onkol; 2020 Jan; 196(1):77-84. PubMed ID: 31591658
[TBL] [Abstract][Full Text] [Related]
19. Low-dose total skin electron beam therapy as a debulking agent for cutaneous T-cell lymphoma: an open-label prospective phase II study.
Kamstrup MR; Lindahl LM; Gniadecki R; Iversen L; Skov L; Petersen PM; Loft A; Specht L
Br J Dermatol; 2012 Feb; 166(2):399-404. PubMed ID: 21967035
[TBL] [Abstract][Full Text] [Related]
20. Low-Dose Hypofractionated Total Skin Electron Beam Therapy for Adult Cutaneous T-Cell Lymphoma.
Jeans EB; Hu YH; Stish BJ; King B; Davis M; Harmsen WS; Fruth KM; Locher SE; Deufel CL; Evans JD; Martenson JA; Lester SC
Pract Radiat Oncol; 2020; 10(6):e529-e537. PubMed ID: 32781247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]